Cassia fistula
Cassia fistula
Cassia fistula, commonly known as the golden shower tree, is a traditional plant with origins in tropical and subtropical regions of Asia and Africa. While its use in traditional medicine has not been extensively documented, it has been employed for various purposes such as ornamental displays due to its vibrant yellow flowers. Scientific evidence indicates potential applications in wastewater treatment through the effective removal of methylene blue (99.5% under optimized conditions), suggesting its utility in environmental remediation. Additionally, studies have identified bioactive compounds from Cassia fistula that may interact with targets involved in respiratory disease management, hinting at multifactorial therapeutic actions. Notably, no significant safety concerns or drug interactions have been recorded for this plant.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study developed a single-tube multiplex SCAR assay for the precise identification of Senna alexandrina and its adulterant species.
- The CS_CFF_AgNPs nanocomposite film exhibited improved antioxidant, antimicrobial, and wound-healing properties.
- Cassia fistula pod waste-derived mesoporous carbon achieved high methylene blue removal (99.5%) under optimized conditions, showing promise for wastewater treatment.
- The study identified potential bioactive compounds from Cassia fistula and other plants that interact with targets involved in respiratory disease management, suggesting multifactorial therapeutic actions.
- The study found that Neisseria elongata-derived exosomes conjugated with Cassia fistula extract showed concentration-dependent cytotoxic effects and modulated signaling pathways in pancreatic cancer cells.
Frequently asked questions
What is Cassia fistula?
Cassia fistula (Cassia fistula) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Cassia fistula?
5 sourced findings are recorded for Cassia fistula; the strongest carries evidence grade D. For example: The study developed a single-tube multiplex SCAR assay for the precise identification of Senna alexandrina and its adulterant species.
How strong is the evidence for Cassia fistula?
The strongest finding for Cassia fistula carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Cassia fistula safe? What are the side effects?
No major safety issues are recorded for Cassia fistula in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Cassia fistula interact with medications?
No drug interactions are recorded for Cassia fistula in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Cassia fistula?
Cassia fistula is also known as: Кассия трубчатая.
Is Cassia fistula a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Development of One-Tube Multiplex Arbitrary (RAPD and ISSR) Marker-Based SCAR Assay for Simultaneous Detection and Authentication of Indian Senna (Senna alexandrina Mill.) and Its Adulterant Species. literature abstract metadata
- T2 Design and Development of Chitosan-Based Nanocomposite Films Enriched with Tailored AgNPs Derived from Cassia fistula Flower Extract for Biotherapeutic Applications. literature abstract metadata
- T2 Network pharmacology-based therapeutic illustration of Indian medicinal plants in respiratory disorders. literature abstract metadata
- T2 Valorization of Cassia fistula pod waste into mesoporous carbon for the adsorptive removal of dye pollutant. literature abstract metadata
- T2 Oral microbiota member Neisseria elongata exosomes-Cassia fistula association targets PTEN/AKT/IL10/IL1β/BAX/BCL-2 signaling pathway in pancreatic cancer immunotherapy. literature abstract metadata